Background: Data about food-induced anaphylaxis in Italy are missing. Objective: It was the aim of this study to detect the main foods/food allergens causing anaphylaxis in Italy. Methods: The frequency of anaphylaxis and the relative importance of many offending foods were assessed in 1,110 adult patients with food allergy diagnosed by common criteria at 19 allergy centres scattered throughout Italy from 1 January to 31 December 2007. Results: Fifty-eight of 1,110 (5%) food-allergic patients experienced at least 1 episode of anaphylaxis. On average, they were older than other food-allergic patients (34 vs. 31 years; p < 0.05). The majority of anaphylactic episodes occurred in patients sensitized to lipid transfer protein (LTP; n = 19), followed by shrimp (n = 10), tree nuts (n = 9), legumes other than peanut (n = 4), and seeds (n = 2); peanut, spinach, celery, buckwheat, wheat, avocado, tomato, fish, meat, and Anisakis caused an anaphylactic reaction in single patients. Among LTP-hypersensitive patients, peach caused 13/19 anaphylactic episodes. Shrimp-allergic patients were significantly older than other patients with food-induced anaphylaxis (p < 0.05), whereas patients allergic to LTP experienced their anaphylactic episodes at a younger age (p < 0.001). The frequency of anaphylaxis among patients sensitized to LTP, shrimp or tree nuts did not differ between northern and central/southern Italy. Conclusion: LTP is the most important allergen causing food-induced anaphylaxis in Italy, peach being the most frequently offending food. Peanut-induced anaphylaxis seems very uncommon. Geographic and environmental differences both between Italy and other countries and within Italy seem to play a relevant role in the pattern of sensitization to foods.

Keywords:
Food-induced anaphylaxis, Food allergy
1.
Yocum MW, Khan DA: Assessment of patients who have experienced anaphylaxis: a 3-year survey. Mayo Clin Proc 1994;69:16–23.
2.
Pumphrey RSH, Stanworth SJ: The clinical spectrum of anaphylaxis in north-west England. Clin Exp Allergy 1996;26:1364–1370.
3.
Sampson HA: Fatal food-induced anaphylaxis. Allergy 1998;53:125–130.
4.
Sampson HA, Mendelson L, Rosen JP: Fatal and near-fatal anaphylactic reactions to foods in children and adolescents. N Engl J Med 1992;327:380–384.
5.
Bock SA, Munoz-Furlong A, Sampson HA: Fatalities due to anaphylactic reactions to food. J Allergy Clin Immunol 2001;107:191–193.
6.
Pumphrey RS: Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000;30:1144–1150.
7.
Ewan PW: Clinical study of peanut and nut allergy in 62 consecutive patients: new features and associations. BMJ 1996;312:1074–1078.
8.
Le TM, Lindner TM, Pasmans SG, Guikers CLH, Van Hoffen E, Bruijnzeel-Koomen CAFM, Knulst AC: Reported food allergy to peanut, tree nuts and fruit: comparison of clinical manifestations, prescription of medication and impact on daily life. Allergy 2008;63:910–916.
9.
Boros CA, Kay D, Gold MS: Parent reported allergy and anaphylaxis in 4173 South Australian children. J Paediatr Child Health 2000;36:36–40.
10.
Kemp SF, Lockey RF, Wolf BL, Liebermann P: Anaphylaxis. A review of 266 cases. Arch Intern Med 1995;155:1749–1754.
11.
Ross MP, Ferguson M, Street D, Klontz K, Schroeder T, Luccioli S: Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System. J Allergy Clin Immunol 2008;121:166–171.
12.
Thong BY, Cheng YK, Leong KP, Tang CY, Chang HH: Anaphylaxis in adults referred to a clinical immunology/allergy centre in Singapore. Singapore Med J 2005;46:529–534.
13.
Brown AF, McKinnon D, Chu K: Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 2001;108:861–866.
14.
Moneret-Vautrin DA, Kanny G, Morisset M, Rancè F, Fardeau MF, Beaudouin E: Severe food anaphylaxis: 107 cases registered in 2002 by the Allergy Vigilance Network. Eur Ann Allergy Clin Immunol 2004;36:46–51.
15.
Helbling A, Hurni T, Mueller UR, Pichler WJ: Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004;34:285–290.
16.
Gonzalez Galan I, Garcia Menaya JM, Jimenez Ferrera G, Gonzalez Mateos G: Anaphylactic shock to oysters and white fish with generalized urticaria to prawns and white fish. Allergol Immunopathol (Madr) 2002;30:300–303.
17.
Pastorello EA, Rivolta F, Bianchi M, Mauro M, Pravettoni V: Incidence of anaphylaxis in the emergency department of a general hospital in Milan. J Chromatogr B Biomed Sci Appl 2001;756:11–17.
18.
Asero R, Antonicelli L, Arena A, Bommarito L, Caruso B, Crivellaro M, et al: EpidemAAITO: prevalence and features of food allergy in Italian adults. A multicentre study. Clin Exp Allergy 2009;39:547–555.
19.
Amlot P, Kemeny DM, Zachary C, Parker P, Lessof MH: Oral allergy syndrome (OAS) symptoms of IgE-mediated hypersensitivity to foods. Clin Allergy 1987;17:33–42.
20.
Sampson HA: Adverse reactions to foods; in Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER (eds): Allergy. Principles and Practice, ed 6. St Louis, Mosby, 2003, pp 1619–1643.
21.
Johansson SGO, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haathela T, Kowalski ML, et al: A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813–824.
22.
Sampson HA, Munoz Furlong A, Campbell RL, Adkinson NF, Bock SA, et al: Second symposium on the definition and management of anaphylaxis: summary report – Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117:391–397.
23.
Dreborg S, Frew A: Allergen standardization and skin tests. EAACI position paper. Allergy 1993;48:49–75.
24.
Gonzalez-Mancebo E, Fernandez-Rivas M: Outcome and safety of double-blind, placebo-controlled food challenges in 111 patients sensitized to lipid transfer proteins. J Allergy Clin Immunol 2008;121:1507–1508.
25.
Asero R, Mistrello G, Roncarolo D, Casarini M, Falagiani P: Allergy to non-specific lipid transfer proteins in Rosaceae: a comparative study of different in vivo diagnostic methods. Ann Allergy Asthma Immunol 2001;87:68–71.
26.
Asero R: Plant food allergy. A suggested approach to allergen-resolved diagnosis in the clinical practice by identifying easily available sensitisation markers. Int Arch Allergy Immunol 2005;138:1–11.
27.
Asero R, Mistrello G, Roncarolo D, Amato S: Relationship between peach lipid transfer protein specific IgE levels and hypersensitivity to non-Rosaceae vegetable foods in patients allergic to lipid transfer protein. Ann Allergy Asthma Immunol 2004;92:268–272.
28.
Pastorello EA, Vieths S, Pravettoni V, Farioli L, Trambaioli C, Fortunato D, et al: Identification of hazelnut major allergens in sensitive patients with positive double blind, placebo-controlled food challenge results. J Allergy Clin Immunol 2002;109:563–560.
29.
Pastorello EA, Farioli L, Pravettoni V, Robino AM, Scibilia J, Fortunato D, Conti A, Borgonovo L, Bengtsson A, Ortolani C: Lipid transfer protein and vicilin are important walnut allergens in patients not allergic to pollen. J Allergy Clin Immunol 2004;114:908–914.
30.
Lombardero M, Garcia Selles FJ, Polo F, Jimeno L, Chamorro MJ, et al: Prevalence of sensitization to Artemisia allergens Art v 1, Art v 3 and Art v 60 kDa. Cross-reactivity among Art v 3 and other relevant lipid-transfer protein allergens. Clin Exp Allergy 2004;34:1415–1421.
31.
Lauer I, Miguel-Moncin MS, Abel T, Foetisch K, Hartz C, et al: Identification of a plane pollen lipid transfer protein (Pla a 3) and its immunological relation to the peach lipid-transfer protein, Pru p 3. Clin Exp Allergy 2007;37:261–269.
32.
Asero R, Mistrello G, Amato S, Roncarolo D, et al: Peach fuzz contains large amounts of lipid transfer protein: is this the cause of the high prevalence of sensitization to LTP in Mediterranean countries? Eur Ann Allergy Clin Immunol 2006;38:118–121.
33.
Borghesan F, Mistrello G, Roncarolo D, Amato S, et al: Respiratory allergy to lipid transfer protein. Int Arch Allergy Immunol 2008;147:161–165.
34.
Asero R, Bolhaar STH, Gonzalez-Mancebo E, Fernandez-Rivas M, Knulst A, Hoffmann-Sommergruber K, Zuidmeer L, van Ree R, Sancho A, Rigby NR, Miles S: Are the different prevalences of sensitisation to lipid transfer protein throughout Europe related to food consumption habits? XXIII EAACI Congress, Amsterdam, June 2004.
35.
Flinterman AE, Akkerdaas JH, den Hartog Jager CF, Rigby NM, Fernandez-Rivas M, Hoekstra MO, et al: Lipid transfer protein-linked hazelnut allergy in children from a non-Mediterranean birch-endemic area. J Allergy Clin Immunol 2008;121:423–428.
36.
Mondoulet L, Paty E, Drumare MF, Ah-Leung S, Scheinmann P, Willemot RM, Wal JM, Bernard H: Influence of thermal processing on the allergenicity of peanut proteins. J Agric Food Chem 2005;53:4547–4553.
37.
Dalal I, Binson I, Reifen R, Amitai Z, Shohat T, Rahmani S, et al: Food allergy is a matter of geography after all: sesame as a major cause of severe IgE-mediated food allergic reactions among infants and young children in Israel. Allergy 2002;57:362–365.
38.
Vadas P, Gold M, Perelman B, Liss GM, Lack G, et al: Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008;358:28–35.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.